Athanase Innovation Valuation Multiples

Discover revenue and EBITDA valuation multiples for Athanase Innovation and similar public comparables like Inversiones Union Espanola, Palmboomen Cultuur, Audacia, Accentis and more.

Athanase Innovation Overview

About Athanase Innovation

Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.


Founded

2016

HQ

Sweden

Employees

43

Financials (FY)

Revenue: $5M
EBITDA: ($5M)

EV

$4M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Athanase Innovation Financials

Athanase Innovation reported last fiscal year revenue of $5M and negative EBITDA of ($5M).

In the same fiscal year, Athanase Innovation generated ($1M) in gross profit, ($5M) in EBITDA losses, and had net loss of ($6M).


Athanase Innovation P&L

In the most recent fiscal year, Athanase Innovation reported revenue of $5M and EBITDA of ($5M).

Athanase Innovation is unprofitable as of last fiscal year, with gross margin of (26%), EBITDA margin of (100%), and net margin of (132%).

See analyst estimates for Athanase Innovation
Last FY2025202620272028
Revenue$5M$5M
Gross Profit($1M)($1M)
Gross Margin(26%)(26%)
EBITDA($5M)($5M)
EBITDA Margin(100%)(100%)
EBIT Margin(133%)(133%)
Net Profit($6M)($6M)
Net Margin(132%)(132%)

Financial data powered by Morningstar, Inc.

Athanase Innovation Stock Performance

Athanase Innovation has current market cap of $40M, and enterprise value of $4M.

Market Cap Evolution


Athanase Innovation's stock price is $2.13.

Athanase Innovation share price increased by 0.4% in the last year.

Athanase Innovation has an EPS (earnings per share) of $-0.32.

See more trading valuation data for Athanase Innovation
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4M$40M0.5%-0.0%15.2%0.4%$-0.32

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Athanase Innovation Valuation Multiples

Athanase Innovation trades at 0.8x EV/Revenue multiple, and (0.8x) EV/EBITDA.

See NTM and 2027E valuation multiples for Athanase Innovation

Athanase Innovation Financial Valuation Multiples

As of September 5, 2026, Athanase Innovation has market cap of $40M and EV of $4M.

Athanase Innovation has a P/E ratio of (6.6x).

Last FY2025202620272028
EV/Revenue0.8x0.8x
EV/EBITDA(0.8x)(0.8x)
EV/EBIT(0.6x)(0.6x)
EV/Gross Profit(3.2x)(3.2x)
P/E(6.6x)(6.6x)
EV/FCF(0.5x)(0.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Athanase Innovation Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Athanase Innovation Margins & Growth Rates

In the most recent fiscal year, Athanase Innovation reported gross margin of (26%), EBITDA margin of (100%), and net margin of (132%).

See estimated margins and future growth rates for Athanase Innovation

Athanase Innovation Margins

Last FY2025202720282029
Gross Margin(26%)(26%)
EBITDA Margin(100%)(100%)
EBIT Margin(133%)(133%)
Net Margin(132%)(132%)
FCF Margin(155%)(155%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Athanase Innovation Operational KPIs

Athanase Innovation's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.

Access forward-looking KPIs for Athanase Innovation
Last FY2025202620272028
Revenue per Employee$0.1M-
Opex per Employee$0.3M-
Opex to Revenue273%273%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Athanase Innovation Competitors

Athanase Innovation competitors include Inversiones Union Espanola, Palmboomen Cultuur, Audacia, Accentis, Altus, WT Financial Group, Numulae Gestion De, RedFish LongTerm Capital, Acanthe Developpement and VBARE Iberian Properties.

Most Athanase Innovation public comparables operate across Asset Management.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Inversiones Union Espanola8.2x-9.3x-
Palmboomen Cultuur----
Audacia2.0x2.0x16.0x72.6x
Accentis5.6x-16.9x-
Altus0.1x-0.5x-
WT Financial Group0.2x-7.6x-
Numulae Gestion De5.6x-17.2x-
RedFish LongTerm Capital1.3x-11.4x-

This data is available for Pro users. Sign up to see all Athanase Innovation competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Athanase Innovation

When was Athanase Innovation founded?Athanase Innovation was founded in 2016.
Where is Athanase Innovation headquartered?Athanase Innovation is headquartered in Sweden.
How many employees does Athanase Innovation have?As of today, Athanase Innovation has over 43 employees.
Is Athanase Innovation publicly listed?Yes, Athanase Innovation is a public company listed on Nasdaq Stockholm.
What is the stock symbol of Athanase Innovation?Athanase Innovation trades under ATIN ticker.
When did Athanase Innovation go public?Athanase Innovation went public in 2017.
Who are competitors of Athanase Innovation?Athanase Innovation main competitors include Inversiones Union Espanola, Palmboomen Cultuur, Audacia, Accentis, Altus, WT Financial Group, Numulae Gestion De, RedFish LongTerm Capital, Acanthe Developpement, VBARE Iberian Properties.
What is the current market cap of Athanase Innovation?Athanase Innovation's current market cap is $40M.
What is the current revenue of Athanase Innovation?Athanase Innovation's last fiscal year revenue is $5M.
What is the current EV/Revenue multiple of Athanase Innovation?Current revenue multiple of Athanase Innovation is 0.8x.
Is Athanase Innovation profitable?No, Athanase Innovation is not profitable.
How many companies Athanase Innovation has acquired to date?Athanase Innovation hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Athanase Innovation has invested to date?Athanase Innovation hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Athanase Innovation

Lists including Athanase Innovation

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial